Publication | Closed Access
Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
41
Citations
0
References
2004
Year
The investigated multimodality treatment regimen was well-tolerated and prolonged survival while improving patients' quality of life.